发明申请
US20140308685A1 ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME
有权
能够结合周期蛋白的特定区域的抗体以及使用其测量周期蛋白的方法
- 专利标题: ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME
- 专利标题(中): 能够结合周期蛋白的特定区域的抗体以及使用其测量周期蛋白的方法
-
申请号: US14342996申请日: 2012-09-06
-
公开(公告)号: US20140308685A1公开(公告)日: 2014-10-16
- 发明人: Kenji Izuhara , Shoichiro Ohta , Kazuhiko Arima , Hiroshi Shiraishi , Shoichi Suzuki , Tomoaki Hoshino , Yoshinori Azuma , Junya Ono
- 申请人: Kenji Izuhara , Shoichiro Ohta , Kazuhiko Arima , Hiroshi Shiraishi , Shoichi Suzuki , Tomoaki Hoshino , Yoshinori Azuma , Junya Ono
- 申请人地址: JP Tokyo JP Kurume-shi, Fukuoka JP Saga-shi, Saga
- 专利权人: SHINO-TEST CORPORATION,KURUME UNIVERSITY,SAGA UNIVERSITY
- 当前专利权人: SHINO-TEST CORPORATION,KURUME UNIVERSITY,SAGA UNIVERSITY
- 当前专利权人地址: JP Tokyo JP Kurume-shi, Fukuoka JP Saga-shi, Saga
- 优先权: JP2011-194323 20110906; JP2012-077774 20120329
- 国际申请: PCT/JP2012/072774 WO 20120906
- 主分类号: G01N33/68
- IPC分类号: G01N33/68 ; C07K16/18
摘要:
The present invention provides a method and a reagent for measuring periostin contained in a sample with improved accuracy, a method for improving accuracy in measurement of periostin, and a method of testing for pulmonary fibrosis or interstitial pneumonia with improved accuracy. The antibody of the present invention binds to at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin or a cleavage product thereof. The method and the reagent for measuring periostin and the method for improving accuracy in periostin measurement of the present invention is characterized by detecting at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin. The method of testing for pulmonary fibrosis or interstitial pneumonia of the present invention includes the steps of a) measuring the amount or concentration of periostin in a sample derived from a subject, which measuring includes detecting at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin and b) comparing the amount or concentration of the periostin in the sample derived from the subject with an amount or concentration of periostin in a sample derived from a living body not suffering from pulmonary fibrosis and interstitial pneumonia.
公开/授权文献
信息查询
IPC分类: